|
UPF3A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.364600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.875200E-01 |
| Normal-vs-Stage2 |
7.554200E-01 |
| Normal-vs-Stage3 |
5.166100E-02 |
| Normal-vs-Stage4 |
6.358600E-01 |
| Stage1-vs-Stage2 |
7.392600E-01 |
| Stage1-vs-Stage3 |
1.873680E-02 |
| Stage1-vs-Stage4 |
6.297200E-01 |
| Stage2-vs-Stage3 |
9.767600E-02 |
| Stage2-vs-Stage4 |
4.963400E-01 |
| Stage3-vs-Stage4 |
2.880000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.254000E-01 |
| Normal-vs-AfricanAmerican |
1.439170E-01 |
| Normal-vs-Asian |
2.745600E-01 |
| Caucasian-vs-AfricanAmerican |
4.923300E-03 |
| Caucasian-vs-Asian |
3.930000E-01 |
| AfricanAmerican-vs-Asian |
1.033390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.987800E-01 |
| Normal-vs-Female |
8.000400E-01 |
| Male-vs-Female |
6.754000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.671200E-01 |
| Normal-vs-Extreme_Weight |
6.082600E-01 |
| Normal-vs-Obese |
8.182000E-01 |
| Normal-vs-Extreme_Obese |
9.367400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.230800E-01 |
| Normal_Weight-vs-Obese |
2.920400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.709400E-01 |
| Extreme_Weight-vs-Obese |
3.567400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.028000E-01 |
| Obese-vs-Extreme_Obese |
8.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.014800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.157400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.799400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.850100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.284220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.119200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.816000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.016100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.889800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.326030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.013000E-01 |
| Normal-VS-Type2 PRCC |
3.357000E-03 |
| Normal-VS-KIRP CIMP |
1.784000E-02 |
| Normal-VS-Unclassified PRCC |
8.040000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.64440041980652E-10 |
| Type1 PRCC-VS-KIRP CIMP |
1.162140E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.053970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.861600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.476200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.847600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.122000E-02 |
| Normal-vs-N1 |
3.804800E-01 |
| Normal-vs-N2 |
1.144410E-01 |
| N0-vs-N1 |
5.778000E-01 |
| N0-vs-N2 |
2.758600E-01 |
| N1-vs-N2 |
2.953800E-01 |
|
|
